Greylin Investment Management’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,900
| Closed | -$415K | – | 93 |
|
|
2021
Q3 | $415K | Buy |
+18,900
| New | +$415K | 0.09% | 69 |
|
|
2016
Q2 | – | Sell |
-10,300
| Closed | -$69K | – | 71 |
|
|
2016
Q1 | $69K | Sell |
10,300
-4,850
| -32% | -$32.5K | 0.02% | 69 |
|
|
2015
Q4 | $130K | Sell |
15,150
-7,650
| -34% | -$65.6K | 0.03% | 74 |
|
|
2015
Q3 | $125K | Sell |
22,800
-22,300
| -49% | -$122K | 0.03% | 57 |
|
|
2015
Q2 | $256K | Sell |
45,100
-4,900
| -10% | -$27.8K | 0.06% | 51 |
|
|
2015
Q1 | $228K | Hold |
50,000
| – | – | 0.05% | 57 |
|
|
2014
Q4 | $228K | Sell |
50,000
-39,500
| -44% | -$180K | 0.05% | 57 |
|
|
2014
Q3 | $728K | Sell |
89,500
-1,700
| -2% | -$13.8K | 0.17% | 39 |
|
|
2014
Q2 | $877K | Buy |
91,200
+6,300
| +7% | +$60.6K | 0.21% | 34 |
|
|
2014
Q1 | $1M | Buy |
84,900
+33,200
| +64% | +$392K | 0.24% | 33 |
|
|
2013
Q4 | $798K | Buy |
+51,700
| New | +$798K | 0.2% | 41 |
|